{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7360,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-3c75-771d-8191-b888d43821c6",
      "docSlug": "5718bfe4d9722641e9efd52c1efe3e24",
      "documentTitle": "Freightos | Investor Presentation Deck | 34 slides",
      "authorId": "freightos",
      "authorName": "Freightos",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "appendix_data",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3c75-771d-8191-b888d43821c6/34",
      "deckHref": "/decks/019de076-3c75-771d-8191-b888d43821c6",
      "deckAnchorHref": "/decks/019de076-3c75-771d-8191-b888d43821c6#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/FeZgHvAC4YbnswO7RvIeGreYHSnv84AEISxmYIQO1AA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ODNhOTVmOTgwMmM2YmZlNjgzYTQ1NTFlZjMxNWUxNy9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/1",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/DSIe_GdxBneJnkfQbxNXWi_JtVfZ7cVTx5PeiWi602g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ODNhOTVmOTgwMmM2YmZlNjgzYTQ1NTFlZjMxNWUxNy9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/QCmPaMZ6bDuaKD5wmX9b8rFGHyD7F_IjJqDucnfoIXQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ODNhOTVmOTgwMmM2YmZlNjgzYTQ1NTFlZjMxNWUxNy9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/TJ2hswdtFC_gJsZSalIg-pOFAv7yka-lQbsJecR607U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81ODNhOTVmOTgwMmM2YmZlNjgzYTQ1NTFlZjMxNWUxNy9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/2",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a five-column layout to present key investment pillars.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/3",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "ba79782c-3953-40c9-bb39-e7ed4948f66b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The deck starts by outlining key messages and the company's strategy, which is similar to addressing a problem or market need.",
          "position": 0,
          "confidence": 0.7,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide title mentions 4 key messages, but only 2 are presented on this page.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/4",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "ba79782c-3953-40c9-bb39-e7ed4948f66b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The deck starts by outlining key messages and the company's strategy, which is similar to addressing a problem or market need.",
          "position": 0,
          "confidence": 0.7,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/5",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "ba79782c-3953-40c9-bb39-e7ed4948f66b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The deck starts by outlining key messages and the company's strategy, which is similar to addressing a problem or market need.",
          "position": 0,
          "confidence": 0.7,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "key_messages",
      "function": "diagnose_problem",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/6",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "b5c77ba9-e981-4a7a-9df7-efdd8de5fc20",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The CQP update and technology diversification strategy sections present a solution to the problem outlined earlier.",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "key_messages",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/7",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "b5c77ba9-e981-4a7a-9df7-efdd8de5fc20",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The CQP update and technology diversification strategy sections present a solution to the problem outlined earlier.",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "key_messages",
      "function": "frame_situation",
      "notes": "The slide uses a structured approach to justify a capital allocation decision based on external regulatory environments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/8",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "2f831858-4b4d-4f60-9f1b-a1d0f3ce03e0",
          "evidence": "The section on Timing of project development driven by CQP and Financing addresses the question of why now is the right time for the project.",
          "position": 0,
          "objective": "Explain the timing of project development",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "b5c77ba9-e981-4a7a-9df7-efdd8de5fc20",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The CQP update and technology diversification strategy sections present a solution to the problem outlined earlier.",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "key_messages",
      "function": "plan_implementation",
      "notes": "CQP likely refers to Customer Qualification Process; FID refers to Final Investment Decision; SOP refers to Start of Production.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/9",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 8,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "2f831858-4b4d-4f60-9f1b-a1d0f3ce03e0",
          "evidence": "The section on Timing of project development driven by CQP and Financing addresses the question of why now is the right time for the project.",
          "position": 0,
          "objective": "Explain the timing of project development",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.6,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "b5c77ba9-e981-4a7a-9df7-efdd8de5fc20",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The CQP update and technology diversification strategy sections present a solution to the problem outlined earlier.",
          "position": 1,
          "confidence": 0.7,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "other",
      "function": "establish_context",
      "notes": "The slide uses a two-column layout to contrast the 'why' (rationale) and the 'how/when' (status) of a corporate action.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/10",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-10",
      "loopMatches": [
        {
          "to": 11,
          "from": 10,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "79b3bd57-3a1f-4c87-a794-adfe9ca53a71",
          "evidence": "The sections on Preserving liquidity, extending the runway and ensuring optionality and financial discipline discuss the consequences of not taking action.",
          "position": 1,
          "objective": "Highlight the importance of preserving liquidity and financial discipline",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "b3720900-3e66-4040-9d24-e2cd73a12cac",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "The sections on REDOMICILE UPDATE, KPI OVERVIEW, and financial discipline discuss the company's financial situation and plans.",
          "position": 2,
          "confidence": 0.7,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The slide uses a waterfall chart to explain the cash position change.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/11",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-11",
      "loopMatches": [
        {
          "to": 11,
          "from": 10,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "79b3bd57-3a1f-4c87-a794-adfe9ca53a71",
          "evidence": "The sections on Preserving liquidity, extending the runway and ensuring optionality and financial discipline discuss the consequences of not taking action.",
          "position": 1,
          "objective": "Highlight the importance of preserving liquidity and financial discipline",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "b3720900-3e66-4040-9d24-e2cd73a12cac",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "The sections on REDOMICILE UPDATE, KPI OVERVIEW, and financial discipline discuss the company's financial situation and plans.",
          "position": 2,
          "confidence": 0.7,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/12",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "b3720900-3e66-4040-9d24-e2cd73a12cac",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Financials",
          "beatSlug": "sequoia-pitch-financials",
          "evidence": "The sections on REDOMICILE UPDATE, KPI OVERVIEW, and financial discipline discuss the company's financial situation and plans.",
          "position": 2,
          "confidence": 0.7,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "key_takeaways",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/13",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 13,
          "beatId": "19877079-11cd-4711-97f6-d2015e665fa0",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "The Ask",
          "beatSlug": "sequoia-pitch-the-ask",
          "evidence": "The final pages summarize the key takeaways and the way forward, which can be seen as a call to action or a request for support.",
          "position": 3,
          "confidence": 0.7,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3d0a-7376-9238-063a1087922f",
      "docSlug": "583a95f9802c6bfe683a4551ef315e17",
      "documentTitle": "Freyr | Results Presentation Deck | 14 slides",
      "authorId": "freyr",
      "authorName": "FREYR",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3d0a-7376-9238-063a1087922f/14",
      "deckHref": "/decks/019de076-3d0a-7376-9238-063a1087922f",
      "deckAnchorHref": "/decks/019de076-3d0a-7376-9238-063a1087922f#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 14,
          "from": 13,
          "beatId": "19877079-11cd-4711-97f6-d2015e665fa0",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "The Ask",
          "beatSlug": "sequoia-pitch-the-ask",
          "evidence": "The final pages summarize the key takeaways and the way forward, which can be seen as a call to action or a request for support.",
          "position": 3,
          "confidence": 0.7,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/ijfOM51_ySsDslFQKg9RVJRCgLNT5R-gkY0cb3Y2bzg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGFkOWE1ODk0ZTkzYjZhZjhiMWI1YmRkZDJkODdlMy9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/1",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/BXOASGtxugmj-RHIfAo9A8_U9GX1cgBKE3lodx9f3Ro/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGFkOWE1ODk0ZTkzYjZhZjhiMWI1YmRkZDJkODdlMy9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/nh1_daqh49O73o1V-12l6R4tRbos3VWjh5coPBof4vg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGFkOWE1ODk0ZTkzYjZhZjhiMWI1YmRkZDJkODdlMy9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/hRzQFQ_pJsGB1fcRw7fVoVHmubYv6vgty6GvJVkH5nE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82MGFkOWE1ODk0ZTkzYjZhZjhiMWI1YmRkZDJkODdlMy9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/2",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "The slide uses a combination of bulleted benefits and a visual process diagram to explain the mechanism of action.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/3",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-3",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "63f52651-897c-47e3-a629-7d503894345b",
          "evidence": "The document presents a clear and compelling case for why radiopharmaceuticals are poised to become a primary pillar of modern cancer therapy",
          "position": 0,
          "objective": "Why now is the right time for radiopharmaceuticals",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.8,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "bf4c6577-ee3e-4666-8cc2-b252ab138221",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The document highlights the growing importance of radiopharmaceuticals in cancer therapy and the limitations of current treatments",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "unfair_advantage",
      "function": "present_framework",
      "notes": "The slide uses a linear process flow to highlight competitive differentiation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/4",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-4",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "63f52651-897c-47e3-a629-7d503894345b",
          "evidence": "The document presents a clear and compelling case for why radiopharmaceuticals are poised to become a primary pillar of modern cancer therapy",
          "position": 0,
          "objective": "Why now is the right time for radiopharmaceuticals",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.8,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "bf4c6577-ee3e-4666-8cc2-b252ab138221",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The document highlights the growing importance of radiopharmaceuticals in cancer therapy and the limitations of current treatments",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization to represent drug development stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/5",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-5",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Why Now",
          "slug": "15-why-now",
          "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
          "matchId": "63f52651-897c-47e3-a629-7d503894345b",
          "evidence": "The document presents a clear and compelling case for why radiopharmaceuticals are poised to become a primary pillar of modern cancer therapy",
          "position": 0,
          "objective": "Why now is the right time for radiopharmaceuticals",
          "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
          "confidence": 0.8,
          "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "bf4c6577-ee3e-4666-8cc2-b252ab138221",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The document highlights the growing importance of radiopharmaceuticals in cancer therapy and the limitations of current treatments",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide emphasizes vertical integration and strategic supply agreements as a moat.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/6",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-6",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "813974b3-b15c-424a-8d0f-71fe5c945200",
          "evidence": "The document highlights the potential for Fusion Pharmaceuticals' TAT approach to bring first-in-class agents to market",
          "position": 1,
          "objective": "Quick win and big bet on TAT approach",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "9874007f-1efc-436d-b378-6ba4b4f62e19",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents Fusion Pharmaceuticals' innovative TAT approach and its potential to address unmet medical needs",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "summarize",
      "notes": "Includes a logo grid of previous affiliations at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/7",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-7",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "813974b3-b15c-424a-8d0f-71fe5c945200",
          "evidence": "The document highlights the potential for Fusion Pharmaceuticals' TAT approach to bring first-in-class agents to market",
          "position": 1,
          "objective": "Quick win and big bet on TAT approach",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "9874007f-1efc-436d-b378-6ba4b4f62e19",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents Fusion Pharmaceuticals' innovative TAT approach and its potential to address unmet medical needs",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 7,
          "from": 7,
          "beatId": "d8928b4a-72f8-48d2-80d0-ec829ad73a28",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The document highlights the expertise and experience of Fusion Pharmaceuticals' team",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/8",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "813974b3-b15c-424a-8d0f-71fe5c945200",
          "evidence": "The document highlights the potential for Fusion Pharmaceuticals' TAT approach to bring first-in-class agents to market",
          "position": 1,
          "objective": "Quick win and big bet on TAT approach",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "9874007f-1efc-436d-b378-6ba4b4f62e19",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents Fusion Pharmaceuticals' innovative TAT approach and its potential to address unmet medical needs",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a visual case study (Subject #4) showing PET scan response.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/9",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 6,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "813974b3-b15c-424a-8d0f-71fe5c945200",
          "evidence": "The document highlights the potential for Fusion Pharmaceuticals' TAT approach to bring first-in-class agents to market",
          "position": 1,
          "objective": "Quick win and big bet on TAT approach",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "9874007f-1efc-436d-b378-6ba4b4f62e19",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The document presents Fusion Pharmaceuticals' innovative TAT approach and its potential to address unmet medical needs",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "go_to_market",
      "function": "plan_implementation",
      "notes": "Includes a clinical case study image showing patient response to therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/10",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "112b9300-e62a-468e-ab16-1feeb3a2395e",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Opportunity",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "The document discusses the market opportunity for radiopharmaceuticals and the potential for Fusion Pharmaceuticals' therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "product_demo",
      "function": "present_solution",
      "notes": "The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/11",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "112b9300-e62a-468e-ab16-1feeb3a2395e",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Opportunity",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "The document discusses the market opportunity for radiopharmaceuticals and the potential for Fusion Pharmaceuticals' therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a standard clinical trial dose escalation design (3+3) for a radiopharmaceutical.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/12",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 10,
          "beatId": "112b9300-e62a-468e-ab16-1feeb3a2395e",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Opportunity",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "The document discusses the market opportunity for radiopharmaceuticals and the potential for Fusion Pharmaceuticals' therapies",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/13",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide contrasts a chemotherapy-based approach (SMDC) with a radioligand therapy (RLT) approach, highlighting the superior PSA response in the RLT cohort.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/14",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
      "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
      "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
      "authorId": "fusion-pharmaceuticals",
      "authorName": "Fusion Pharmaceuticals",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify market opportunity by tumor type.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/15",
      "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
      "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}